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Methods: Over a 14 year period ending in December
2009, 4619 consecutive CEAs were performed. Interven-
tions were performed in octogenarians in 714 cases (15.5%,
Group 1) and in younger patients in the remaining
3905 (84.5%, Group 2).
Early results in terms of 30-day stroke and death rates
were analyzed and compared.
Follow-up results were analyzed with Kaplan Meyer
curves and compared with log-rank test.
Results: There were no differences between the two
groups in terms of preoperative clinical status or degree of
carotid stenosis on the operated side. Combined 30-day
stroke and death rate was similar between the two groups
(0.7% in group 1 and 1.3% in group 2; p0.1). At univar-
iate analysis, perioperative risk of stroke and death in octo-
genarians was significantly increased only by the presence of
preoperative symptoms (95% CI 0.016-1.2, OR 0.15,
p0.04), but this was not at multivariate analysis.
Follow-up was available in 95.5% of patients with a
mean duration of 39.5 months (range 1-168).
Estimated 7-year survival was significantly lower in
group 1 than in group 2 (89.2% and 85.5%, respectively:
p0.05, log rank 3.9), whereas there were no differences in
terms of stroke-free survival and severe (70%) restenosis-
free survival.
Conclusions: In our experience CEA can be per-
formed in octogenarians with excellent early and long-term
results, even in the presence of lower 7-year survival rates.
Symptomatic patients had a slightly increase in periopera-
tive risk, which however remains largely below the recom-
mended standards.
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Objectives: Carotid angioplasty and stenting (CAS)
has emerged as an alternative for carotid endarterectomy
(CEA) in the prevention of stroke. The benefit of the
procedure, however, is hampered by a suggested higher
incidence of in-stent restenosis (ISR) for CAS relative to
CEA during follow-up. ISR management remains a chal-
lenge for clinicians. In this observational retrospective anal-
ysis, we evaluated the operative management of ISR by
standard CEA with stent removal, including midterm fol-
low-up in 15 patients.
Methods: The present analysis included 15 patients
from three Dutch vascular centers who underwent CEA for
symptomatic (n  10) or hemodynamically significant
(80%) asymptomatic ISR (n  5). Median time between
CAS and CEA was 18.3 months (range, 0-51 months).
Results: Standard CEA with stent removal was per-
formed in all 15 patients. A Javid™ shunt was used in two
procedures. One patient sustained an intraoperative minor
ischemic stroke, with complete recovery during the first
postoperative days. No neurologic complications occurred
in the other 14 patients. Two patients required a reopera-
tion to evacuate a neck hematoma. There were no periph-
eral nerve complications. After a median follow-up of 21
months (range, 3-100 months), all 15 patients remained
asymptomatic and without recurrent restenosis (50%) on
duplex ultrasound imaging.
Conclusions: CEA with stent explantation for ISR
after CAS seems an effective and durable therapeutic op-
tion, albeit with potential cerebral and bleeding complica-
tions, as in this study. The optimal treatment for carotid
ISR, however, has yet to be defined.
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Objectives: Carotid artery stent (CAS) use for the
management of carotid artery disease varies geographically.
We sought to identify temporal trends in CAS versus CEA
utilization and correlates of regional variation.
Methods: We used California (CA) hospital discharge
data from 2005 to 2009 to identify CAS, CEA and index
interventional cardiology (IC) and interventional radiology
(IR) procedures based on hospital referral regions (HRR).
An academic medical center (AMC) was defined as having
an ACGME approved vascular surgery (VS), IC, or IR
training program. We used a Poisson regression model,
with outcomes expressed as incidence rate ratios (IRR),
which is one plus the expected percent change in the
number of CAS, given a one unit change in the indepen-
dent variable.
Results: From 2005 to 2009, 7074 CAS and 40,576
CEA were identified. Annual CEA and CAS fell from
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